Rockefeller Capital Management’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.89M | Buy |
6,377
+123
| +2% | +$39.8K | ﹤0.01% | 1326 |
|
|
2025
Q4 | $1.9M | Buy |
6,254
+116
| +2% | +$38K | ﹤0.01% | 1263 |
|
|
2025
Q3 | $2.09M | Buy |
+6,138
| New | +$1.86M | ﹤0.01% | 1146 |
|
|
2023
Q1 | – | Sell |
-881
| Closed | -$193K | – | 3959 |
|
|
2022
Q4 | $193K | Sell |
881
-4
| -0.5% | -$734 | ﹤0.01% | 1677 |
|
|
2022
Q3 | $119K | Buy |
885
+68
| +8% | +$11.7K | ﹤0.01% | 1894 |
|
|
2022
Q2 | $132K | Sell |
817
-185
| -18% | -$28.9K | ﹤0.01% | 1812 |
|
|
2022
Q1 | $188K | Buy |
1,002
+188
| +23% | +$40K | ﹤0.01% | 1719 |
|
|
2021
Q4 | $220K | Sell |
814
-2
| -0.2% | -$675 | ﹤0.01% | 1608 |
|
|
2021
Q3 | $296K | Sell |
816
-5
| -0.6% | -$1.64K | ﹤0.01% | 1443 |
|
|
2021
Q2 | $281K | Buy |
821
+6
| +0.7% | +$1.99K | ﹤0.01% | 1389 |
|
|
2021
Q1 | $283K | Sell |
815
-8
| -1% | -$2.65K | ﹤0.01% | 1223 |
|
|
2020
Q4 | $212K | Sell |
823
-3
| -0.4% | -$826 | ﹤0.01% | 1174 |
|
|
2020
Q3 | $236K | Sell |
826
-14
| -2% | -$3.29K | ﹤0.01% | 990 |
|
|
2020
Q2 | $158K | Sell |
840
-16
| -2% | -$2.6K | ﹤0.01% | 1024 |
|
|
2020
Q1 | $105K | Sell |
856
-411
| -32% | -$64.3K | ﹤0.01% | 1002 |
|
|
2019
Q4 | $210K | Sell |
1,267
-307
| -20% | -$51K | ﹤0.01% | 756 |
|
|
2019
Q3 | $193K | Sell |
1,574
-234,680
| -99% | -$31.2M | ﹤0.01% | 640 |
|
|
2019
Q2 | $29.3M | Sell |
236,254
-870
| -0.4% | -$110K | 0.41% | 58 |
|
|
2019
Q1 | $31.3M | Buy |
237,124
+8,478
| +4% | +$1.14M | 0.45% | 53 |
|
|
2018
Q4 | $32.1M | Buy |
228,646
+204,621
| +852% | +$27.1M | 0.56% | 45 |
|
|
2018
Q3 | $4.14M | Buy |
24,025
+23,148
| +2,639% | +$3.89M | 0.06% | 128 |
|
|
2018
Q2 | $135K | Buy |
+877
| New | +$156K | ﹤0.01% | 365 |
|
Other funds holding ONC
BBA
HA